Press Releases

SUMMIT, N.J., July 30, 2025 – Kenvue Inc. (NYSE: KVUE) today announced its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock, which represents a 1.2...

Kimberly-Clark Corporation (NYSE: KMB), a global leader in the consumer staples industry, announced today that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global...

Kimberly-Clark Corporation (NYSE: KMB) today announced that Russ Torres, President, North America, has been promoted to President and Chief Operating Officer, effective immediately. As President...

Kimberly-Clark Corporation (NYSE: KMB) today announced plans to invest over $2 billion over the next 5 years in its North America business, marking the company's largest domestic expansion in more...

Kenvue Brands LLC, the maker of Tylenol®, issued the following statement in response to scientifically unfounded litigation filed by the Office of the Attorney General of Texas. What Matters Most...

Kimberly-Clark Corporation (NYSE: KMB) today announced that Joseph Romanelli, president of Human Health International for Merck & Co., Inc., Rahway, NJ, USA, ("MSD") has been elected to its board...

Kimberly-Clark (NYSE: KMB) will issue its third quarter 2024 results on Tuesday, October 22. A press release and supplemental materials will be issued at approximately 6:35 a.m. EDT....

SKILLMAN, N.J., Aug. 15, 2024 — Kenvue Inc. (NYSE: KVUE) (“Kenvue” or the “Company”), the world’s largest pure-play consumer health company by revenue, is launching Neutrogena®1...

The board of directors of Kimberly-Clark Corporation (NYSE: KMB) has declared a regular quarterly dividend of $1.22 per share. The dividend is payable in cash on October 2, 2024, to stockholders...

Delivers net sales of $5.0 billion driven by 4 percent organic sales growth Strong EPS expansion driven by innovation-led volume gains, effective cost management and productivity Company increases...